Melatonin potentiates flavone-induced apoptosis in human colon cancer cells by increasing the level of glycolytic end products

International Journal of Cancer

Volumn 116, Issue 2, 2005, Pages 236-242

  Wenzel, Uwe ^a,b   Nickel, Alexander ^a   Daniel, Hannelore ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b Molecular Nutrition Unit   (Germany)

Author keywords

Cancer cell metabolism; Mitochondrial apoptosis pathway; Superoxide anion generation; Warburg effect

Indexed keywords

5 NITRO 2 (3 PHENYLPROPYLAMINO)BENZOIC ACID; BENZOQUINONE; CAMPTOTHECIN; CASPASE 3; DNA FRAGMENT; FLAVONE; MELATONIN; MONOCARBOXYLATE TRANSPORTER; SINGLET OXYGEN;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL NUCLEUS; CELL PROTECTION; CELL STRAIN HT29; CHROMATIN CONDENSATION; COLON CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; MITOCHONDRION; OXIDATION; PRIORITY JOURNAL;

ANTIOXIDANTS; APOPTOSIS; CASPASE 3; CASPASES; CELL NUCLEUS; COLONIC NEOPLASMS; DNA DAMAGE; FLAVONES; HUMANS; MELATONIN; MITOCHONDRIA; OXIDATION-REDUCTION; TUMOR CELLS, CULTURED;

EID: 22044458158     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/ijc.20837     Document Type: Article

References (45)

1. Sainz RM, Mayo JC, Rodriguez C, Tan DX, Lopez-Burillo S, Reiter RJ. Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 2003;60:1407-26.
2. Chen KB, Lin AM, Chiu TH. Oxidative injury to the locus coeruleus of rat brain: neuroprotection by melatonin. J Pineal Res 2003;35:109-17.
3. Reiter RJ, Sainz RM, Lopez-Burillo S, Mayo JC, Manchester LC, Tan DX. Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann NY Acad Sci 2003;993:35-53.
4. Yu Q, Miller SC, Osmond DG. Melatonin inhibits apoptosis during early B-cell development in mouse bone marrow. J Pineal Res 2000;29:86-93.
5. Maestroni GJ, Hertens E, Galli P, Conti A, Pedrinis E. Melatonin-induced T-helper cell hematopoietic cytokines resembling both interleukin-4 and dynorphin. J Pineal Res 1996;21:131-9.
6. Winczyk K, Pawlikowski M, Karasek M. Melatonin and RZR/ROR receptor ligand CGP 52608 induce apoptosis in the murine colonic cancer. J Pineal Res 2001;31:179-82.
7. Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2000;61:229-39.
8. Hanahan D and Weinberg RA. The hallmarks of cancer. Cell 2000;100:57-70.
9. Anisimov VN, Popovich IG, Slitylik AV, Zabezhinski MA, Ben-Huh H, Gurevich P, Berman V, Tendier Y, Zusman I. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Exp Toxicol Pathol 2000;52:71-6.
10. Winczyk K, Pawlikowski M, Lawnicka H, Kunert-Radek J, Spadoni G, Tarzia G, Karasek M. Effects of melatonin and melatonin receptors ligand N-[(4-methoxy-1H-indol-2-yl)methyl]propanamide on murine Colon 38 cancer growth in vitro and in vivo. Neuro Endocrinol Lett 2002;23:50-4.
11. Chuang JI, Chang TY, Liu HS. Glutathione depletion-induced apoptosis of Ha-ras-transformed NIH3T3 cells can be prevented by melatonin. Oncogene 2003;22:1349-57.
12. Dziegiel P, Podhorska-Okolow M, Surowiak P, Ciesielska U, Rabezynski J, Zabel M. Influence of exogenous melatonin on doxorubicin-evoked effects in myocardium and in transplantable Morris hepatoma in rats. In Vivo 2003;17:325-8.
13. Winczyk K, Pawlikowski M, Guerrero JM, Karasek M. Possible involvement of the nuclear RZR/ROR-alpha receptor in the antitumor action of melatonin on murine Colon 38 cancer. Tumour Biol 2002;23:298-302.
14. Weinreb O, Mandel S, Youdim MB. cDNA gene expression profile homology of antioxidants and their antiapoptotic and proapoptotic activities in human neuroblastoma cells. FASEB J 2003;17:935-7.
15. Leon J, Acuna-Castroviejo D, Sainz RM, Mayo JC, Tan DX, Reiter RJ. Melatonin and mitochondrial function. Life Sci 2004;75:765-90.
16. Bauer G. Signaling and proapoptotic functions of transformed cell-derived reactive oxygen species. Prostaglandins Leukot Essent Fatty Acids 2002;66:41-56.
17. Wenzel U, Kuntz S, Jambor de Sousa U, Daniel H. Nitric oxide suppresses apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions. Int J Cancer 2003;106:666-75.
18. Wenzel U, Nickel A, Kuntz S, Daniel H. Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial Superoxide anions. Carcinogenesis 2004;25:703-12.
19. Wenzel U, Kuntz S, Brendel MD, Daniel H. Dietary flavone selectively induces apoptosis in human colon carcinoma cells. Cancer Res 2000;60:3823-31.
20. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding CK, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, et al. Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 1995;376:37-43.
21. Pou S, Huang YI, Bhan A, Bhadti VS, Hosmane RS, Wu SY, Cao GL, Rosen GM. A fluorophore-containing nitroxide as a probe to detect Superoxide and hydroxyl radical generated by stimulated neutrophils. Anal Biochem 1993;212:85-90.
22. Schagger H, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of proteins in the range from 1 to 100 kDa. Anal Biochem 1987;166:368-79.
23. Wenzel U, Schoberl K, Lohner K, Daniel H. Activation of mitochondrial lactate uptake by flavone induces apoptosis in human colon cancer cells. J Cell Physiol 2005;202:379-90.
24. Allegra M, Reiter RJ, Tan DX, Gentile C, Tesoriere L, Livrea MA. The chemistry of melatonins interaction with reactive species. J Pineal Res 2003;34:1-10.
25. Baydas G, Kutlu S, Naziroglu M, Canpolat S, Sandal S, Ozcan M, Kelestimur H. Inhibitory effects of melatonin on neural lipid peroxidation induced by intracerebroventricular administered homocysteine. J Pineal Res 2003;34:36-9.
26. Liang FQ, Green L, Wang C, Alssadi R, Godley BF. Melatonin protects human retinal pigment epithelial (RPE) cells against oxidative stress. Exp Eye Res 2004;78:1069-75.
27. Cuzzocrea S, Retter RJ. Pharmacological actions of melatonin in acute and chronic inflammation. Curr Top Med Chem 2002;2:153-65.
28. Cuzzocrea S, Reiter RJ. Pharmacological action of melatonin in shock, inflammation and ischemia/reperfusion injury. Eur J Pharmacol 2001;426:1-10.
29. Tsang WP, Chau SP, Kong SK, Fung KP, Kwok TT. Reactive oxygen species mediate doxorubicin induced p53-independent apoptosis. Life Sci 2003;73:2047-58.
30. Liu L, Trimarchi JR, Navarro P, Blasco MA, Keefe DL. Oxidative stress contributes to arsenic-induced telomere attrition, chromosome instability, and apoptosis. J Biol Chem 2003;278:31998-2004.
31. Djavaheri-Mergny M, Wietzerbin J, Besancon F. 2-Methoxyestradiol induces apoptosis in Ewing sarcoma cells through mitochondrial hydrogen peroxide production. Oncogene 2003;22:2558-67.
32. Kurosu T, Fukuda T, Miki T, Miura O. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 2003;22:4459-68.
33. Hockenbery DM, Oltvai ZN, Yin XM, Milliman CL, Korsmeyer SJ. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 1993;75:241-51.
34. Frommel TO, Zarling EJ. Chronic inflammation and cancer: potential role of Bcl-2 gene family members as regulators of cellular antioxidant status Med. Hypotheses 1999;52:27-30.
35. Eck-Enriquez K, Kiefer TL, Spriggs LL, Hill SM. Pathways through which a regimen of melatonin and retinoic acid induces apoptosis in MCF-7 human breast cancer cells. Breast Cancer Res Treat 2000;61:229-39.
36. El-Missiry MA, Abd El-Aziz AF. Influence of melatonin on proliferation and antioxidant system in Ehrlich ascites carcinoma cells. Cancer Lett 2000;151:119-25.
37. Petranka J, Baldwin W, Biermann J, Jayadev S, Barrett JC, Murphy E. The oncostatic action of melatonin in an ovarian carcinoma cell line. J Pineal Res 1999;26:129-36.
38. Clapp-Lilly KL, Smith MA, Perry G, Harris PL, Zhu X, Duffy LK. Melatonin acts as antioxidant and pro-oxidant in an organotypic slice culture model of Alzheimer's disease. Neuroreport 2001;12:1277-80.
39. Medina-Navarro R, Duran-Reyes G, Hicks JJ. Pro-oxidating properties of melatonin in the in vitro interaction with the singlet oxygen. Endocr Res 1999;25:263-80.
40. Jou MJ, Peng TI, Reiter RJ, Jou SB, Wu HY, Wen ST. Visualization of the antioxidative effects of melatonin at the mitochondrial level during oxidative stress-induced apoptosis of rat brain astrocytes. J Pineal Res 2004;37:55-70.
41. Mazurek S, Boschek CB, Eigenbrodt E. The role of phosphometabolites in cell proliferation, energy metabolism, and tumor therapy. J Bioenerg Biomembr 1997;29:315-30.
42. Gatenby RA. The potential role of transformation-induced metabolic changes in tumor-host interaction. Cancer Res 1995;55:4151-6.
43. Yokoyama T, Shirono H, Yamada N, Kato N, Koga J. Utilization of changes in the metabolic rate of melatonin receptor-expressing cells to quantify melatonin. Anal Biochem 1998;255:159-61.
44. Martins E Jr, Fernandes LC, Bartol I, Cipolla-Neto J, Costa Rosa LF. The effect of melatonin chronic treatment upon macrophage and lymphocyte metabolism and function in Walker-256 tumour-bearing rats. J Neuroimmunol 1998;82:81-9.
45. Wang X, Levi AJ, Halestrap AP. Substrate and inhibitor specificities of the monocarboxylate transporters of single rat heart cells. Am J Physiol 1996;270:476-84.